Skip to main content
Log in

A method of detecting and estimating inhibitors of the cancer coagulative factor

  • Published:
Irish Journal of Medical Science (1926-1967)

Summary

A method of testing for neutralisation of the cancer coagulative factor is described.

Of a wide range of substances tested, protamine sulphate, placentalα 1 globulin and placental albumin were found to possess activity worthy of clinical investigation in the treatment of cancer.

Plasmin is also highly active in counteracting the clotting effect of the cancer coagulative factor. Its probable mode of action is unspecific proteolysis, comparable with its effect on many of the recognised factors concerned in coagulation of the blood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • O’Meara, R. A. Q. (1958).Irish J. Med. Sci., vi, 394, 474.

    Google Scholar 

  • O’Meara, R. A. Q. (1960).Arch. de Vecchi, 31, 365.

    PubMed  Google Scholar 

  • O’Meara, R. A. Q., and Thornes, R. D. (1961).Irish J. Med. Sci., vi, 423, 106.

    Google Scholar 

  • Sherry, S., Fletcher, A. D., and Alkjaersig, N. (1959).Physiol. Rev., 39, 343.

    CAS  PubMed  Google Scholar 

  • Thornes, R. D., and Martin, W. T. (1961).In preparation.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thornes, R.D., O’Meara, R.A.Q. A method of detecting and estimating inhibitors of the cancer coagulative factor. Ir J Med Sci 36, 361–365 (1961). https://doi.org/10.1007/BF02953365

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02953365

Navigation